Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, ...

Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...

A new initiative integrated personal continuous glucose monitor reports into routine primary care visits for diabetes.

Keeping tabs on blood sugar throughout the day used to be the exclusive domain of people with diabetes. But in 2026, anyone ...

Analysis of over 5,000 hours of clinical wear data validates Trinity Biotech’s CGM+ 's purpose-built capability to distinguish nocturnal compression-related false lows from true blood glucose lows - ...

The UK's NHS has reported encouraging results from the first large-scale rollout of artificial pancreas systems for type 1 diabetes. The data also shows the technology reached poorer and minority ...

Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...

A read-write wearable both reads your body and writes back to it by delivering an intervention.

The move from read-only tracking to closed-loop intervention is not a marketing tweak. It changes what a wearable is for.

Now a new generation of devices is trying to do something the read-only wearable never could, talk back to the body.

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...